ASC42
Sponsors
Gannex Pharma Co., Ltd., Ascletis Pharmaceuticals Co., Ltd.
Conditions
Healthy
Phase 1
Study to Evaluate Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of ASC42 in Healthy Subjects
CompletedNCT04679129
Start: 2020-11-30End: 2021-06-03Updated: 2024-09-27
Study to Evaluate Safety, Tolerability and Pharmacokinetics of ASC42 in Chinese Healthy Subjects
CompletedNCT04965337
Start: 2021-07-11End: 2021-08-01Updated: 2022-06-30
Drug Interaction Study of ASC42 With Atorvastatin
CompletedNCT05464628
Start: 2022-08-08End: 2022-08-30Updated: 2024-09-27